Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
4DMedical Ltd ( (AU:4DX) ) has provided an update.
4DMedical Ltd announced the issuance of 12,964,580 unquoted equity securities, specifically options expiring on February 29, 2028, with an exercise price of $0.75. This move is likely to impact the company’s financial structure and could influence its market positioning by potentially increasing capital for future projects, affecting stakeholders’ interests.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, focusing on innovative imaging solutions. The company is known for its advanced respiratory imaging products, which aim to enhance diagnostic capabilities and improve patient outcomes.
Average Trading Volume: 3,488,634
Technical Sentiment Signal: Buy
Current Market Cap: A$724.4M
See more insights into 4DX stock on TipRanks’ Stock Analysis page.